IDSA GUIDELINES Bundle (free trial)

Pediatric Community-Acquired Pneumonia

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/63099

Contents of this Issue

Navigation

Page 10 of 25

Table 4. Selection of Antimicrobial Therapy for Specific Pathogens (continued) Pathogen S. aureus, methicillin susceptible (combination therapy not well-studied) Parenteral Therapy Preferred: • Cefazolin (150 mg/kg/day div q8h) or • Semisynthetic penicillin, eg, oxacillin (150-200 mg/kg/day div q6-8h) Alternatives: • Clindamycina (40 mg/kg/day div q6-8h) or S. aureus, methicillin resistant, susceptible to clindamycin (combination therapy not well-studied) S. aureus, methicillin resistant, resistant to clindamycin (combination therapy not well-studied) Haemophilus influenza typeable (A-F) or nontypeable • Vancomycin (40-60 mg/kg/day div q6-8h) Preferred: • Vancomycin (40-60 mg/kg/day div q6-8h or dosing to achieve an AUC/MIC ratio of > 400) or • Clindamycin (40 mg/kg/day div q6-8h) Alternatives: • Linezolid (30 mg/kg/day div q8h for children < 12 y and 20 mg/kg/day div q12h for children ≥ 12 y) Preferred: • Vancomycin (40-60 mg/kg/day div q6-8h or dosing to achieve an AUC/MIC ratio of > 400) Alternatives: • Linezolid (30 mg/kg/day div q8h for children < 12 y and 20 mg/kg/day div q12h for children ≥ 12 y) Preferred: • If β-lactamase negative: ampicillin IV (150-200 mg/kg/day div q6h) or • If β-lactamase producing: ceftriaxone (50-100 mg/kg/day div q12-24h) or cefotaxime (150 mg/kg/day div q8h) Alternatives: • Ciprofloxacin IV (30 mg/kg/day div q12h) or • Levofloxacin IV (16-20 mg/kg/day div q12h for children 6 mo to 5 y and 8-10 mg/kg once daily for children 5 to 16 y; max daily dose, 750 mg) (Step-Down Therapy or Mild Infection) Oral Therapy Preferred: • Cephalexin PO (75-100 mg/kg/day div tid or qid) Alternative: • Clindamycin POa (30-40 mg/kg/day div tid or qid) Preferred: • Clindamycin PO (30-40 mg/kg/day div tid or qid) Alternatives: • Linezolid PO (30 mg/kg/day div tid for children < 12 y and 20 mg/kg/day div bid for children ≥ 12 y) Preferred: • Linezolid PO (30 mg/kg/day div tid for children < 12 y and 20 mg/kg/day div bid for children ≥ 12 y) Alternatives: • None; entire treatment course with parenteral therapy may be required Preferred: • If β-lactamase negative: amoxicillin (75-100 mg/kg/day div tid) or • If β-lactamase producing: amoxicillin/clavulanate (amox component, 45 mg/kg/day div tid or 90 mg/kg/day div bid) Alternatives: • Cefdinir, cefixime, cefpodoxime, or ceftibuten Continued on next page. 9

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Pediatric Community-Acquired Pneumonia